VTechWorks staff will be away for the winter holidays starting Tuesday, December 24, 2024, through Wednesday, January 1, 2025, and will not be replying to requests during this time. Thank you for your patience, and happy holidays!
 

Inhibiting neurotransmitter reuptake

dc.contributor.assigneeVirginia Tech Intellectual Properties, Inc.en
dc.contributor.assigneeMayo Foundation for Medical Edication and Researchen
dc.contributor.departmentChemistryen
dc.contributor.departmentCenter for Drug Discoveryen
dc.contributor.inventorCarlier, Paul R.en
dc.contributor.inventorRichelson, Elliotten
dc.contributor.inventorFauq, Abdul H.en
dc.contributor.inventorMonceaux, Christopher J.en
dc.date.accessed2019-02-15en
dc.date.accessioned2019-02-26T22:24:02Zen
dc.date.available2019-02-26T22:24:02Zen
dc.date.filed2014-03-10en
dc.date.issued2018-04-17en
dc.description.abstractThis document relates to compounds as well as methods and materials involved in modulating neurotransmitter reuptake. For example, compounds, methods for synthesizing compounds, and methods for inhibiting neurotransmitter reuptake are provided. Specifically gamma-amino alcohol derivatives that inhibit the reuptake of neurotransmitters such as dopamine, serotonin, epinephrine or norepinephrine are provided as therapeutic agents for the treatment of depression or anxiety in a mammalian subject.en
dc.format.mimetypeapplication/pdfen
dc.identifier.applicationnumber14776397en
dc.identifier.patentnumber9944618en
dc.identifier.urihttp://hdl.handle.net/10919/87839en
dc.identifier.urlhttp://pimg-fpiw.uspto.gov/fdd/18/446/099/0.pdfen
dc.language.isoen_USen
dc.publisherUnited States Patent and Trademark Officeen
dc.rightsIn Copyrighten
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/en
dc.subject.cpcA61K31/138en
dc.subject.cpcC07D333/28en
dc.subject.cpcC07C211/30en
dc.subject.cpcC07C215/28en
dc.subject.cpcC07C215/30en
dc.subject.cpcC07C215/68en
dc.subject.cpcC07C217/48en
dc.subject.cpcC07C217/62en
dc.subject.cpcC07C217/64en
dc.subject.cpcC07C233/43en
dc.subject.cpcC07C235/06en
dc.subject.cpcC07C235/08en
dc.subject.cpcC07C235/14en
dc.subject.cpcC07C259/06en
dc.subject.cpcC07C323/32en
dc.subject.cpcC07D205/04en
dc.subject.cpcC07D207/12en
dc.subject.cpcC07D213/30en
dc.subject.cpcC07D213/38en
dc.subject.cpcC07D213/61en
dc.subject.cpcC07D213/64en
dc.subject.cpcC07D213/65en
dc.subject.cpcC07D215/06en
dc.subject.cpcC07D261/08en
dc.subject.cpcC07D265/06en
dc.subject.cpcC07D267/10en
dc.subject.cpcC07D271/06en
dc.subject.cpcC07D295/135en
dc.subject.cpcC07D295/185en
dc.subject.cpcC07D295/192en
dc.subject.cpcC07D317/58en
dc.subject.cpcC07D319/18en
dc.subject.cpcC07D333/20en
dc.subject.cpcC07C2601/02en
dc.subject.cpcC07C2601/04en
dc.titleInhibiting neurotransmitter reuptakeen
dc.typePatenten
dc.type.dcmitypeTexten
dc.type.patenttypeutilityen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
9944618.pdf
Size:
11.24 MB
Format:
Adobe Portable Document Format